ES2535430T3 - Métodos para el tratamiento de la endometriosis - Google Patents
Métodos para el tratamiento de la endometriosisInfo
- Publication number
- ES2535430T3 ES2535430T3 ES04769463.3T ES04769463T ES2535430T3 ES 2535430 T3 ES2535430 T3 ES 2535430T3 ES 04769463 T ES04769463 T ES 04769463T ES 2535430 T3 ES2535430 T3 ES 2535430T3
- Authority
- ES
- Spain
- Prior art keywords
- endometriosis
- endometrioma
- medicament
- treatment
- progesterone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
Abstract
Un medicamento para uso en un método para tratar la endometriosis por administración intralesional, comprendiendo el medicamento: una suspensión no basada en aceite que comprende un progestágeno; en el que el medicamento se formula para suministro intralesional y en el que la cantidad de progestágeno administrada por dosis a una lesión es equivalente en actividad a 0,2-5 g de progesterona.
Description
5
10
15
20
25
30
35
E04769463
23-04-2015
en 1.990 cuando se diagnosticó endometriosis de grado 4. Se realizó en aquel momento cirugía reconstructiva pélvica. Con posterioridad experimentó intentos repetidos en tratamiento médico con contraceptivos orales, danazol, y análogos de GNRH de medicamento de liberación lenta. También tuvo un intento de IVF (fecundación in vitro, por sus siglas en inglés) sin éxito. El paciente presentó una demanda de histerectomía ya que la calidad de su vida estaba trastornada debido a dolor pélvico y rectal intenso.
El examen físico y la valoración por ultrasonidos revelaron que presentaba endometrioma ovárico del lado derecho, útero fijado, ovario izquierdo sensible y nódulos adenomióticos uterosacros. Se realizó aspiración transvaginal guiada por ultrasonidos del endometrioma. Se instilaron dos gramos de progesterona en la suspensión del Ejemplo 1 en el endometrioma y se inyectó el nódulo adenomiótico. Se informó la mejora en el dolor pélvico a los 10 días. En las posteriores visitas de seguimiento durante los siguientes 15 meses, no hubo reaparición de los síntomas. Su calidad de vida con respecto a dismenorrea, dispareunia y dolor pélvico mejoró significativamente y no se requirió cirugía invasiva.
Ejemplo 4
37 años con endometriosis en ovario, vejiga urinaria y en la cicatriz.
Una mujer nulípara de 37 años experimentó sección cesárea del segmento inferior en 1.987 por razones obstétricas. Presentó una lesión de la masa en la cicatriz en 1.995. Se eliminó la lesión y se demostró que era endometriosis en la cicatriz. Con posterioridad, en 2.000 se desarrolló dolor pélvico crónico y síntomas urinarios. El examen físico, la ultrasonografía y cistoscopía revelaron endometrioma en el ovario derecho y nódulos endometriósicos en la pared de la vejiga cerca de la cicatriz.
Se realizó la aspiración del endometrioma e instilación intraquística de 1 g de progesterona. Se llevó a cabo cistoscopía y se instiló 1 g de progesterona en cada uno de los módulos en la vejiga.
En el seguimiento durante 12 meses permaneció sin síntomas. La calidad de vida con respecto a dolor pélvico y síntomas urinarios fue buena. Se evitó cirugía pélvica mayor, es decir, histerectomía abdominal total, salpingooferectomía bilateral, escisión de la pared de la vejiga y reconstrucción.
Ejemplo 5
Mujer perimenopáusica, de 43 años, con endometrioma, adenomiosis uterina y dolor pélvico.
En septiembre de 2.001, una mujer nulípara de 43 años se había quejado de dolor pélvico intenso, dolor abdominal inferior izquierdo y dismenorrea intensa. El dolor no se alivió mediante analgésicos regulares y antiespasmódicos. El examen y la ultrasonografía revelaron un útero adenomiótico y endometrioma del ovario izquierdo. Se había asesorado al paciente a fin de que se le practicara una histerectomía abdominal total, pero solicitó tratamiento conservador y deseó evitar la posibilidad de cirugía y pérdida de sus ovarios.
Se realizó aspiración transvaginal del endometrioma y se instilaron en la cavidad 2 g de progesterona en la suspensión del Ejemplo 1. Esto fue seguido por progesterona micronizada intravaginal durante 8 semanas. El paciente conservó sus ovarios y se ha mantenido sin síntomas durante casi 2 años.
8
Claims (1)
-
imagen1 imagen2
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50021703P | 2003-09-03 | 2003-09-03 | |
US500217P | 2003-09-03 | ||
US52635503P | 2003-12-01 | 2003-12-01 | |
US526355P | 2003-12-01 | ||
PCT/IB2004/003103 WO2005020880A2 (en) | 2003-09-03 | 2004-08-27 | Methods for the treatment of endometriosis |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2535430T3 true ES2535430T3 (es) | 2015-05-11 |
Family
ID=34278698
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES04769463.3T Active ES2535430T3 (es) | 2003-09-03 | 2004-08-27 | Métodos para el tratamiento de la endometriosis |
Country Status (22)
Country | Link |
---|---|
US (2) | US9532995B2 (es) |
EP (2) | EP1660009B1 (es) |
JP (2) | JP5651279B2 (es) |
KR (2) | KR101288265B1 (es) |
CN (1) | CN101849906A (es) |
AU (1) | AU2004267956B2 (es) |
BR (1) | BRPI0413200A (es) |
CA (1) | CA2537702C (es) |
DK (1) | DK1660009T3 (es) |
EA (1) | EA015356B1 (es) |
ES (1) | ES2535430T3 (es) |
HK (1) | HK1095529A1 (es) |
HR (1) | HRP20150440T1 (es) |
HU (1) | HUE025239T2 (es) |
IL (1) | IL174014A0 (es) |
MA (1) | MA28083A1 (es) |
NO (1) | NO20061502L (es) |
PL (1) | PL1660009T3 (es) |
PT (1) | PT1660009E (es) |
SI (1) | SI1660009T1 (es) |
TN (1) | TNSN06070A1 (es) |
WO (1) | WO2005020880A2 (es) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11287425B2 (en) | 2009-04-22 | 2022-03-29 | Juneau Biosciences, Llc | Genetic markers associated with endometriosis and use thereof |
US20080306034A1 (en) * | 2007-06-11 | 2008-12-11 | Juneau Biosciences, Llc | Method of Administering a Therapeutic |
WO2009140126A1 (en) * | 2008-05-14 | 2009-11-19 | Juneau Biosciences, Llc | Method of administering a therapeutic |
EP2471537A1 (en) * | 2010-12-30 | 2012-07-04 | PregLem S.A. | Treatment of pain associated with dislocation of basal endometrium |
AR082266A1 (es) * | 2011-05-13 | 2012-11-28 | Univ Nac Del Litoral | Microparticula inyectable de liberacion controlada |
JP6285866B2 (ja) | 2011-11-23 | 2018-02-28 | セラピューティックスエムディー インコーポレーテッドTherapeuticsmd, Inc. | 天然複合ホルモン補充製剤および療法 |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US20160287710A1 (en) * | 2013-11-12 | 2016-10-06 | Margit Maria JANAT-AMSBURY | Glycol chitin based thermosensitive hydrogel for vaginal delivery of progesterone |
AU2015264003A1 (en) | 2014-05-22 | 2016-11-17 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
MX2016013693A (es) | 2014-07-29 | 2017-10-31 | Therapeuticsmd Inc | Crema transdermica. |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
WO2017173071A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
CA3038897A1 (en) * | 2016-09-28 | 2018-04-05 | Atossa Genetics Inc. | Methods of adoptive cell therapy |
RU2661701C1 (ru) * | 2017-02-09 | 2018-07-19 | федеральное государственное автономное образовательное учреждение высшего образования "Российский университет дружбы народов" (РУДН) | Способ лапароскопического лечения узловых форм аденомиоза |
US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
CN115605187A (zh) * | 2020-02-26 | 2023-01-13 | 福多兹制药公司(Us) | 载有孕激素药物的可注射控释制剂 |
RU2746476C1 (ru) * | 2020-04-28 | 2021-04-14 | федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) | Способ хирургического лечения глубокого инфильтративного эндометриоза ректовагинальной перегородки |
GB2594726A (en) * | 2020-05-05 | 2021-11-10 | Nadezhda Reproductive Science Ood | Adenomyosis associated infertility and HDACIs |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US61303A (en) * | 1867-01-15 | James yocom | ||
US150A (en) | 1837-03-25 | Island | ||
US5362A (en) | 1847-11-06 | Ice-ctjttee | ||
US4038A (en) | 1845-05-10 | Boot-crimp | ||
US720A (en) | 1838-04-28 | Improved mode of forming a kiln for making charcoal | ||
US5543A (en) | 1848-05-02 | of jbesey city | ||
US12703A (en) * | 1855-04-10 | Gabhst-chaie | ||
US389A (en) | 1837-09-21 | Mode of supporting the bodies of railroad-cars and carriages | ||
US3089815A (en) | 1951-10-11 | 1963-05-14 | Lieb Hans | Injectable pharmaceutical preparation, and a method of making same |
GB784659A (en) * | 1954-11-26 | 1957-10-16 | Upjohn Co | Therapeutic compositions and aqueous suspensions thereof |
US4038389A (en) * | 1975-05-07 | 1977-07-26 | The Upjohn Company | Medroxyprogesterone acetate compositions |
FR2663223B1 (fr) | 1990-06-14 | 1994-12-02 | Af Aplicaciones Far Lab | Forme galenique parenterale. |
GB2252497B (en) | 1991-02-04 | 1995-01-18 | Elsimar Metzker Coutinho | Pharmaceutical composition |
JPH0735335B2 (ja) | 1991-02-28 | 1995-04-19 | 五十嵐 正雄 | 子宮内膜症の治療薬 |
ZA924811B (en) * | 1991-06-28 | 1993-12-29 | Endorecherche Inc | Controlled release systems and low dose androgens |
HU222501B1 (hu) | 1991-06-28 | 2003-07-28 | Endorecherche Inc. | MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására |
RU2073534C1 (ru) | 1993-06-04 | 1997-02-20 | Сочинский научно-исследовательский институт курортологии и физиотерапии МЗ РФ | Способ лечения генитального эндометриоза |
US5543150A (en) | 1993-09-15 | 1996-08-06 | Columbia Laboratories, Inc. | Method of progesterone delivery and affect thereof |
PT792152E (pt) * | 1994-11-22 | 2004-07-30 | Balance Pharmaceuticals Inc | Metodos de contracepcao |
EP0785212A1 (en) | 1996-01-22 | 1997-07-23 | Laboratoire Theramex | New 19-nor-pregnene derivatives |
US6416778B1 (en) * | 1997-01-24 | 2002-07-09 | Femmepharma | Pharmaceutical preparations and methods for their regional administration |
US5993856A (en) | 1997-01-24 | 1999-11-30 | Femmepharma | Pharmaceutical preparations and methods for their administration |
US6265393B1 (en) * | 1998-08-07 | 2001-07-24 | Heinrichs William Leroy | Prevention of endometriosis signs or symptons |
US6287602B1 (en) | 1998-09-16 | 2001-09-11 | Oncopharmaceutical, Inc. | Treatment of oncologic tumors with an injectable formulation of a Golgi apparatus disturbing agent |
BR9906862A (pt) * | 1998-10-09 | 2001-11-27 | Upjohn Co | Uso de uma quantidade eficaz de um agente desubstituição hormonal para o tratamento demenopausa humana e de endometriose |
JP2001051773A (ja) * | 1999-08-16 | 2001-02-23 | Toshiaki Matsuhashi | キーボードカバー |
US6613355B2 (en) * | 2000-05-11 | 2003-09-02 | A.P. Pharma, Inc. | Semi-solid delivery vehicle and pharmaceutical compositions |
AU2001262228A1 (en) * | 2000-05-15 | 2001-11-26 | Pharmacia Italia S.P.A. | Stabilized steroidal suspension |
US6495534B2 (en) * | 2000-05-15 | 2002-12-17 | Pharmacia & Upjohn Spa | Stabilized aqueous suspensions for parenteral use |
US6495164B1 (en) * | 2000-05-25 | 2002-12-17 | Alkermes Controlled Therapeutics, Inc. I | Preparation of injectable suspensions having improved injectability |
US6696483B2 (en) | 2000-10-03 | 2004-02-24 | Oncopharmaceutical, Inc. | Inhibitors of angiogenesis and tumor growth for local and systemic administration |
US20020072509A1 (en) * | 2000-10-11 | 2002-06-13 | Stein Donald Gerald | Methods for the treatment of a traumatic central nervous system injury |
DE60231862D1 (de) | 2001-02-23 | 2009-05-20 | Genentech Inc | Erodierbare polymere zur injektion |
JP4273208B2 (ja) * | 2001-03-30 | 2009-06-03 | チッソ株式会社 | 婦人科疾患治療剤 |
US20040105889A1 (en) | 2002-12-03 | 2004-06-03 | Elan Pharma International Limited | Low viscosity liquid dosage forms |
-
2004
- 2004-08-27 PL PL04769463T patent/PL1660009T3/pl unknown
- 2004-08-27 SI SI200432237T patent/SI1660009T1/sl unknown
- 2004-08-27 DK DK04769463.3T patent/DK1660009T3/en active
- 2004-08-27 WO PCT/IB2004/003103 patent/WO2005020880A2/en active Application Filing
- 2004-08-27 ES ES04769463.3T patent/ES2535430T3/es active Active
- 2004-08-27 CN CN201010193233A patent/CN101849906A/zh active Pending
- 2004-08-27 JP JP2006525216A patent/JP5651279B2/ja active Active
- 2004-08-27 EP EP04769463.3A patent/EP1660009B1/en active Active
- 2004-08-27 AU AU2004267956A patent/AU2004267956B2/en active Active
- 2004-08-27 KR KR1020117031425A patent/KR101288265B1/ko active IP Right Grant
- 2004-08-27 BR BRPI0413200-9A patent/BRPI0413200A/pt not_active Application Discontinuation
- 2004-08-27 EA EA200600524A patent/EA015356B1/ru not_active IP Right Cessation
- 2004-08-27 HU HUE04769463A patent/HUE025239T2/en unknown
- 2004-08-27 KR KR1020067004304A patent/KR101285137B1/ko active IP Right Grant
- 2004-08-27 PT PT47694633T patent/PT1660009E/pt unknown
- 2004-08-27 EP EP13164182.1A patent/EP2617411A1/en not_active Withdrawn
- 2004-08-27 CA CA2537702A patent/CA2537702C/en active Active
- 2004-08-27 US US10/927,822 patent/US9532995B2/en active Active
-
2006
- 2006-02-28 IL IL174014A patent/IL174014A0/en unknown
- 2006-03-01 TN TNP2006000070A patent/TNSN06070A1/en unknown
- 2006-04-03 NO NO20061502A patent/NO20061502L/no not_active Application Discontinuation
- 2006-04-03 MA MA28910A patent/MA28083A1/fr unknown
-
2007
- 2007-03-12 HK HK07102652.8A patent/HK1095529A1/xx unknown
-
2012
- 2012-10-05 JP JP2012222814A patent/JP2013035866A/ja active Pending
-
2014
- 2014-10-27 US US14/524,639 patent/US9468647B2/en active Active
-
2015
- 2015-04-22 HR HRP20150440TT patent/HRP20150440T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2535430T3 (es) | Métodos para el tratamiento de la endometriosis | |
Monteagudo et al. | Saline infusion sonohysterography in nonpregnant women with previous cesarean delivery: the" niche" in the scar. | |
Ko et al. | Sonographic and MR findings in 2 cases of intramural pregnancy treated conservatively | |
Goker et al. | Rectus abdominis muscle endometriosis | |
Burney et al. | Menstrual bleeding from an endometriotic lesion | |
Patel et al. | Laparoscopic management of an ovarian entopic pregnancy: Case report | |
Le et al. | Clinical analysis of 95 cases with ovarian pregnancy | |
Chopra et al. | AN UNUSUAL CASE OF A LARGE CERVICAL ANGIOLEIOMYOMA MANAGED LAPAROSCOPICALLY. | |
Ko et al. | Laparoscopic electrodessication of an interstitial pregnancy | |
Bano et al. | Endometriosis-A Crippling Illness: A Rare Case Of Bladder Endometrioma. | |
CA | CAESAREAN SCAR PREGNANCY-A CLINICAL DILEMMA | |
Gupta et al. | Caesarian Scar Pregnancy-A Diagnostic Dilemma. | |
Priyamvada | A Comparative Study to Assess the Accuracy of Transvaginal Sonography and Saline Infusion Hysterosonography in Comparision with Histopathological Examination of Endometrial Biopsy in Detecting the Cause of Abnormal Uterine Bleeding | |
Goel et al. | CHRONIC UTERINE INVERSION ASSOCIATED WITH FIBROID-A CASE REPORT | |
Sreenivas | The Role of Transvaginal Ultrasonography and Endometrial Biopsy in the Evaluation of Abnormal Uterine Bleeding | |
Pathade et al. | Scar endometriosis: an uncommon surgical aftermath | |
Guessan et al. | A Rare Discovery of a Voluminous Cervical Myoma Prolapsed Out of the Introitus at Day 15 Post Spontaneous Vaginal Delivery | |
Tian et al. | Primary perineal endometriosis–a case report and literature review | |
Marsidi et al. | and Jennifer Fay Kawwass | |
Hewawitharanaa et al. | A case report on cystic adenomyosis: A rare variant of uterine adenomyosis | |
Pratiksha Gupta et al. | Caesarian scar pregnancy-a diagnostic dilemma. | |
Harris et al. | Leiomyomata and Reproduction | |
Satheshkumar et al. | ULTRASONOGRAPHIC DIAGNOSIS OF A LIVE ECTOPIC FOETUS IN A COW | |
Hajihashemi et al. | Prolonged Intrauterine Fetal Bone Retention Following a Neglected Pregnancy: A Case Report | |
Turhan et al. | CASE REPORT–OPEN ACCESS |